BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging
Clinical trial NCT05552508 · COMPLETED
Trial details
- NCT number
- NCT05552508
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-11
- Primary completion
- 2024-07-19
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.